- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
NephroGenex Inc+ Add to Watchlist
NRX:US9.8400 USD 0.3999 3.91%
As of 20:10:00 ET on 03/13/2014.
Company Profile for NephroGenex Inc (NRX)
NephroGenex, Inc. develops novel drugs for the treatment of kidney disease. The Company is developing a small molecule drug that acts as an inhibitor of the pathogenic oxidative chemistries which are elevated in diabetic patients.
Key Executives for NephroGenex Inc (NRX)
|Pierre LegaultChief Executive Officer||J Wesley FoxPres/Chief Scientific Ofcr|
|John P HamillChief Financial Officer||Mark A KlausnerChief Medical Ofcr|
|Bob PetersonVP:Product Dev||Pepper LandsonVP:Clinical Operations|
|Carrie TaylorVP:Clinical Development|